Indian Pharma
Global Entry Strategy
Capitalize on the $200B global patent cliff. This dashboard provides a data-driven path for Maharashtra-based exporters to navigate semi-regulated markets (ROW) and US-FDA nutraceutical compliance.
Strategic Execution Roadmap
The first year is critical for building a foundation of "Trust Infrastructure." Success requires moving from domestic licensing to international outreach in a strict sequence.
Licensing Foundation
Secure DGFT IEC, Maharashtra FDA Wholesale License, and FSSAI Central License for exports.
Dossier Submission
Goal: Compare (Market Speed)
Submit eCTD dossiers to DIGEMID (Peru) or PPB (Kenya). Register facility with US FDA.
Matchmaking & Sales
Exhibit at CPHI India. Launch LinkedIn Sales Navigator campaigns for procurement directors.
Logistics Execution
Execute first bulk shipment. Deploy Amazon FBA inventory. Finalize FSVP documentation.
ROW Market Selection
Semi-regulated jurisdictions represent the fastest "velocity-to-revenue" path. While highly regulated markets require years of study, these nations prioritize WHO-GMP certification for rapid generic entry.
Peru (DIGEMID)
45-90 Day auto-approval mechanism for Category 1.
Uzbekistan (CIS)
Simplified recognition (Decree No. 862) within 15-60 days.
Kenya (PPB)
90-day target timeline with EAC regional springboard potential.
Market Velocity vs. Regulatory Cost
Data Goal: Compare categories by approval speed and fee structure. Bar Chart selected for clear ranking.
US Dietary Supplement Workflow
Bypassing B2B via Amazon FBA requires navigating a strict post-market surveillance framework. Use this workflow to manage the critical US-FDA touchpoints.
FDA Facility
Register Maharashtra facility as a US Food Facility. Designate a US Agent.
COA & Label
Secure ISO 17025 Certificate of Analysis. Ensure "No Medical Claims" on labels.
Customs Bond
Secure Continuous US Customs Bond ($50k coverage) for new tariff rules.
FSVP Agent
Appoint US-based FSVP Agent to verify hazard analysis and safety protocols.
Amazon FBA
File FDA Prior Notice. Ship to US. Amazon handles B2C consumer fulfillment.
Capital Allocation: Initial Single Drug Setup (INR)
Data Goal: Show composition of initial regulatory spend. Doughnut chart used for part-to-whole emphasis.
Financial Modeling
Initial capital is heavily weighted toward foreign regulatory inspections. The total required setup capital for a single generic dossier in a market like Kenya is approximately ₹6,00,000.
Global Matchmaking Hub
Digital legitimacy is non-negotiable. Leverage these high-fidelity directories to connect with verified wholesale importers.
Pipelinepharma
Hosts 72,000+ dossiers and 93,000 formulations. No brokerage fees.
Pharmatradz
Marketplace for out-licensing finished dosages and API sourcing.
PharmaManch
Critical bridge for sourcing from vetted WHO-GMP Indian manufacturers.
CPHI Online
Digital extension of the world's largest pharma trade show franchise.
Pharmahook
Actionable lead generation for international wholesalers and distributors.
Deploy AI Scraper Agent
Django/Spring AI enabled